#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16104	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2271	854.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	1040	C,T,A	1037,1,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3967	860.9	0	.	n	.	0	T695C	SNP	695	695	T	1257	1257	C	1004	C,T,A,G	998,2,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3967	860.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1899	1899	A	1111	A,C	1109,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3967	860.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2533	2533	C	990	C	988	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3967	860.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2607	2607	A	931	A,C	930,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3967	860.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3159	3159	C	963	C	963	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2404	folP	855	855	100.0	folP.l15.c4.ctg.1	1990	150.4	1	SNP	p	R229S	0	.	.	685	687	CGC	1217	1219	CGC	232;232;231	C;G;C,G,A	232;232;229,1,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5414	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3988	169.1	1	SNP	p	S91F	0	.	.	271	273	TCC	909	911	TCC	198;195;195	T;C,T;C,A	198;194,1;194,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5414	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3988	169.1	1	SNP	p	D95G	0	.	.	283	285	GAC	921	923	GAC	191;190;190	G;A,G,C;C	191;188,1,1;190	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5414	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3988	169.1	1	SNP	p	D95N	0	.	.	283	285	GAC	921	923	GAC	191;190;190	G;A,G,C;C	191;188,1,1;190	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2106	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1906	137.6	1	SNP	p	G45D	1	.	.	133	135	GAC	748	750	GAC	232;231;231	G;A,G;C	232;230,1;231	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1272	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1428	110.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5434	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3454	196.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1883	1885	GCA	273;268;265	G;C,G;A,C	273;267,1;264,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5434	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3454	196.2	1	SNP	p	D86N	0	.	.	256	258	GAC	836	838	GAC	230;230;226	G;A;C,T	230;230;225,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5434	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3454	196.2	1	SNP	p	S87I	0	.	.	259	261	AGT	839	841	AGT	227;227;227	A;G;T	227;227;227	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5434	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3454	196.2	1	SNP	p	S87R	0	.	.	259	261	AGT	839	841	AGT	227;227;227	A;G;T	227;227;227	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5434	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3454	196.2	1	SNP	p	S87W	0	.	.	259	261	AGT	839	841	AGT	227;227;227	A;G;T	227;227;227	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5434	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3454	196.2	1	SNP	p	S88P	0	.	.	262	264	TCC	842	844	TCC	227;226;227	T,A;C;C	226,1;226;227	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4768	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2954	200.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1669	1671	GGC	261;258;255	G,T,C;G;C	259,1,1;258;255	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1570	1572	GCA	254;257;253	G,C;C;A	253,1;257;253	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1573	1575	ATC	252;249;251	A;T;C,A	252;249;250,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1585	1587	GTG	247;251;252	G,T,C;T,C;G,C	245,1,1;249,2;251,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1585	1587	GTG	247;251;252	G,T,C;T,C;G,C	245,1,1;249,2;251,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2089	2091	ACC	270;270;272	A;C;C,A	269;270;270,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2143	2145	GCG	238;237;236	G;C;G,C	237;237;233,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2143	2145	GCG	238;237;236	G;C;G,C	237;237;233,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2266	2268	GGC	246;248;248	G;G;C	246;248;248	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2275	2277	GGC	248;246;250	G,T;G;C	247,1;246;250	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4448	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	185.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2293	2295	CTG	239;237;239	C;T,A;G,T	239;236,1;238,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5944	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3587	206.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1886	1888	CCG	235;234;233	C;C;G	235;234;233	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2714	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2236	151.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	582	584	GGC	208;207;206	G,A;G;C	207,1;207;206	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2714	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2236	151.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	764	764	C	196	C,T	195,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	62	64	ACT	68;68;68	A;C;T	68;68;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	68	70	GAT	68;68;68	G;A;T	68;68;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	71	73	AGT	68;68;68	A;G;T	68;68;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	80	82	CAC	68;68;68	C;A;C	68;68;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	R307K	NONSYN	919	921	AGA	170	172	AAA	3;3;3	A;A;A	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	182	184	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	185	187	GAC	4;4;4	G;A;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	191	193	ATC	5;5;5	A;T;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	197	199	TCG	5;5;5	T;C;G	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	203	205	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	206	208	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	209	211	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	302	porB1a	984	232	90.95	porB1a.l15.c4.ctg.1	621	22.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	215	217	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	679	681	GGA	269;267;268	G;G;A	269;267;268	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	V75I	NONSYN	223	225	GTT	760	762	ATT	260;261;260	A,G,T;T;T,G,C	258,1,1;261;258,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	T89S	NONSYN	265	267	ACC	802	804	AGC	258;254;254	A;G,T;C	258;252,1;254	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	V98I	NONSYN	292	294	GTC	829	831	ATC	222;220;218	A,G;T,G;C	220,2;219,1;218	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	.	MULTIPLE	358	359	AA	894	895	CG	187;183	C;G	187;183	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	.	MULTIPLE	361	362	GA	897	899	CAG	179;178;179	C,G;A,G,C;G	178,1;175,2,1;179	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	N122K	NONSYN	364	366	AAC	901	903	AAA	180;182;181	A;A;A,C	180;182;180,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	F131H	NONSYN	391	393	TTT	928	930	CAT	180;180;180	C;A,G;T	180;179,1;180	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	N134E	NONSYN	400	402	AAT	937	939	GAG	180;180;179	G;A,G;G	180;179,1;179	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	V135L	NONSYN	403	405	GTG	940	942	CTT	180;182;185	C;T;T	180;182;185	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	G140K	NONSYN	418	420	GGA	955	957	AAA	191;192;189	A;A;A	191;192;189	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	K143E	NONSYN	427	429	AAA	964	966	GAA	185;186;183	G;A;A	185;186;183	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	V151A	NONSYN	451	453	GTA	988	990	GCA	207;207;205	G,A;C;A	206,1;207;205	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	Y212_T213insFI	INS	634	634	T	1171	1171	T	254	T,G	252,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1300	1302	CAA	188;184;183	C,G;A;A	187,1;184;183	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	.	INDELS	760	762	ACA	1304	1308	ATCAA	181;182;176;177;178	A;T,A;C;A,C;A	181;180,2;176;176,1;178	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	.	INDELS	763	764	TG	1311	1313	AGT	175;174;172	A;G;T,G	175;174;171,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1318	1320	GAT	175;176;176	G;A;T	175;176;176	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1426	1428	AGT	213;214;215	A,C;G;T	211,1;214;215	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1432	1434	GAC	216;216;220	G;A;C	216;216;220	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	0	.	p	.	0	E326K	NONSYN	976	978	GAA	1525	1527	AAA	247;251;256	A;A;A	246;250;255	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	1	SNP	p	G120K	1	.	.	358	360	AAG	894	896	CGG	187;183;179	C;G;G	187;183;179	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	1	SNP	p	A121D	1	.	.	361	363	GAC	897	900	CGC	179;179;179	C,G;G;C,G	178,1;179;178,1	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2678	porB1b	1041	1041	95.83	porB1b.l6.c4.ctg.1	2119	157.4	1	SNP	p	D121N	0	.	.	361	363	GAC	897	900	CGC	179;179;179	C,G;G;C,G	178,1;179;178,1	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	242	porB3	990	157	94.27	porB3.l15.c4.ctg.5	162	52.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	68;68;68	A;C;T	68;68;68	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	242	porB3	990	157	94.27	porB3.l15.c4.ctg.5	162	52.4	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	68;68;68	A;G;T	68;68;68	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	242	porB3	990	157	94.27	porB3.l15.c4.ctg.5	162	52.4	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	68;68;68	G;A;C	68;68;68	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	242	porB3	990	157	94.27	porB3.l15.c4.ctg.5	162	52.4	0	.	p	.	0	R279H	NONSYN	835	837	CGC	80	82	CAC	68;68;68	C;A;C	68;68;68	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10046	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5349	234.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1542	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1316	144.8	1	SNP	p	V57M	1	.	.	169	171	ATG	627	629	ATG	270;269;270	A,G;T;G	269,1;269;270	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
